CLEAR Launches CLEAR ID: A New, Free Way to Present Your ID at TSA Checkpoints with the CLEAR Mobile App NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- CLEAR (NYSE: YOU), the secure identity company, today announced the launch of CLEAR ID—a free, mobile digital ID that allows travelers to verify their identity at more than 250 TSA checkpoints directly from their phones using the CLEAR Mobile App, allowing them to keep their physical ID in their bag. With CLEAR ID, U.S. passport holders can easily create and securely store a TSA-accepted digital ID in the CLEAR App for domestic travel. Once ...
CLEAR Announces Contract with CMS to Power Secure, Seamless Digital Identity for Medicare.gov Contract enables integration of CLEAR1 to modernize account creation and recovery for Medicare beneficiaries and providers, strengthen fraud prevention, and advance the connected digital health ecosystem NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) -- CLEAR (NYSE: YOU), the secure identity company, today announced it has entered into a contract with the Centers for Medicare & Medicaid Services (CMS), the single largest payer for health care services in the United States, to support modernization of...
A director at Sensient Technologies Corp sold 4,518 shares at 94.809USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...
Biodesix to Present New Data at Two Major Upcoming Scientific Meetings Clinical utility data for Nodify Lung® tests to be presented at North American Conference on Lung Cancer (NACLC) highlighting potential for earlier diagnosis of lung cancer Development data for a new ultra-sensitive ESR1 assay for breast cancer treatment resistance monitoring to be presented at San Antonio Breast Cancer Symposium (SABCS) LOUISVILLE, Ky., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, announces several poster presentations on lung cancer diagn...
Key Findings:US hotel RevPAR growth has been flat QTD through November, improving from -1% Y/Y in 3Q, but stable with 2Q. Specifically, RevPAR grew +1% Y/Y MTD in November, accelerating from -1% Y/Y in October.International RevPAR growth has improved to the high-single-digit range QTD, from low- to
Report Overview: Our analysis includes total web visits (desktop and mobile) to U.S. and international web domains, mobile app monthly active users (MAUs), daily active users (DAUs), and total time spent (where applicable). Throughout the report, we display Y/Y changes across each of these key metr
Post-results, we think the disconnect between fundamentals and investor sentiment offers attractive upside for the highest-quality names in our coverage. We’ve become more constructive on the companies below:META (Outperform) - We are adding Meta Platforms to the Best Ideas List and maintain our $9
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Figure 1. 3Q25 ResultsSource: Company reports, Wedbush estimates, FactSet consensusAirbnb reported strong 3Q results and provided a healthy outlook for 4Q. Nights and Experiences booked growth in 3Q of +8.8% Y/Y was ~150bps above Street estimates. Revenue was in line with expectations, while adj. E
Figure 1. 3Q25 Results vs. ExpectationsSource: Company reports, Wedbush estimates, FactSet consensusClear reported 3Q results ahead of estimates. Bookings growth of +14.3% Y/Y in 3Q was approximately ~190bps above consensus, and Clear delivered adj. EBITDA of $70mm (30.6% margin), exceeding the Str
CLEAR Announces Third Quarter 2025 Financial Results NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Clear Secure, Inc. (NYSE: YOU), the secure identity company, has released financial results for the third quarter of fiscal year of 2025 on its Investor Relations website at Third Quarter Financial Highlights(percentage change is expressed as year-over-year, unless otherwise specified) Revenue of $229.2 million was up 15.5%; Total Bookings of $260.1 million were up 14.3%Operating income of $52.6 million, representing a 23.0% Operating income marginNet income of $45.1 million, representing a...
Biodesix Announces Third Quarter 2025 Results and Highlights Q3 2025 Revenue of $21.8 million, an increase of 20% over Q3 2024; Q3 2025 gross profit margin of 81%, a 400-basis point improvement from Q3 2024; Raised FY2025 Total Revenue Guidance to $84-86 million; Conference Call and Webcast Today at 4:30 p.m. ET LOUISVILLE, Colo., Nov. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: BDSX), a leading diagnostic solutions company, today announced its financial and operating results for the third quarter ended September 30, 2025. “We delivered a strong third quarter with revenue growing 20% to $...
Biodesix to Share its R&D Roadmap during its Corporate Day Presentation at AMP Annual Meeting Speaker panel will include collaborative case study presentations from strategic partners: Memorial Sloan Kettering Cancer Center, Bio-Rad Laboratories, and Thermo Fisher Scientific LOUISVILLE, Colo., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, announces its Corporate and Scientific presentations, and exhibitor presence at the 2025 AMP Annual Meeting, November 12-15, in Boston, MA. BIODESIX WORKSHOP: On November 12, at 4:00 ET, Dr. ...
CLEAR To Announce Third Quarter 2025 Financial Results On November 6, 2025 NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Clear Secure, Inc. (NYSE: YOU), the secure identity platform, today announced that it will report financial results for the third quarter ending September 30, 2025 at approximately 6:00 a.m. ET on Thursday, November 6, 2025. At 8:00 a.m. ET, results will be discussed via live webcast and teleconference. Investors and analysts can access the live teleconference call by dialing toll-free 877-407-3089 for U.S. participants and for international participants. Listeners ...
Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing LOUISVILLE, Colo., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc. (NYSE: BDSX), a leading diagnostics solutions company, today announced the signing of an expanded partnership agreement under which Biodesix will conduct the development, clinical validation, and regulatory submissions of in vitro diagnostic (IVD) assays to enable highly sensi...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.